2
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Superior Cervical Ganglionectomy Depresses Norepinephrine Uptake, Increases the Density of α-Adrenoceptor Sites, and Induces Supersensitivity to Adrenergic Drugs in Rat Medial Basal Hypothalamus

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The occurrence of nonpineal mediated effects of superior cervical ganglionectomy (SCGx) on neuroendocrine function prompted us to study SCGx effects on medial basal hypothalamic (MBH) norepinephrine (NE) content and uptake, and on MBH α- and β-adrenoceptor sites assessed by <sup>3</sup>H-dihydroergocryptine and <sup>3</sup>H-dihydroalprenolol binding. SCGx depressed MBH NE uptake but did not affect NE content in MBH homogenates. After SCGx, a significant 35% increase of α-adrenoceptor sites occurred in MBH whereas the β-adrenoceptors remained unchanged. In order to correlate the increase of binding sites with adrenoceptor-mediated supersensitive responses in MBH, the effects on NE, isoprotere-nol or L-dihydroxyphenylalanine (L-dopa) on MBH tubulin concentration were assessed. Each drug brought about a greater depression of MBH tubulin in SCGx than in control rats. A dose-response study of the MBH tubulin decrease after L-dopa treatment indicated that SCGx augmented the potency of L-dopa by 2.5-fold, shifting the dose-response curve to the left in a parallel manner. Such increase in potency was only 1.6-fold when SCGx was associated with Px. SCGx increased both α- and β-adrenoceptor sensitivity of MBH tubulin. Px, while leaving the α-adrenoceptor supersensitive response unmodified, removed the β-adrenoceptor-mediated effect on tubulin because: (i) isoproterenol injection did not affect MBH tubulin in SCGx-Px rats; (ii) NE or L-dopa induced a depression of MBH tubulin which was partially impaired by propranolol in SCGx rats and was refractory to β-adrenergic blockade in SCGx-Px animals; (iii) the α-adrenergic blocker phentolamine abolished effectively NE or L-dopa effect on MBH tubulin in SCGx-Px rats but not in SCGx rats. Dose-related decreases of cerebral cortex tubulin after L-dopa treatment were essentially similar in SCGx, SCGx-Px or sham-operated rats. These results indicate that SCGx depresses NE uptake and increases α-adrenoceptor sites in MBH as well as the adrenoceptor-mediated response of MBH tubulin. A functionally relevant link between superior cervical ganglia and MBH appears to occur in the rat.

          Related collections

          Author and article information

          Journal
          NEN
          Neuroendocrinology
          10.1159/issn.0028-3835
          Neuroendocrinology
          S. Karger AG
          0028-3835
          1423-0194
          1981
          1981
          26 March 2008
          : 33
          : 4
          : 199-206
          Affiliations
          Centro de Estudios Farmacológicos y de Principios Naturales, and Instituto de Investigaciones Farmacólogicas, Buenos Aires, Argentina
          Article
          123229 Neuroendocrinology 1981;33:199–206
          10.1159/000123229
          6270586
          © 1981 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 8
          Categories
          Original Paper

          Comments

          Comment on this article